Processing

Please wait...

Settings

Settings

1. WO2002002109 - USE OF GALIELLA LACTONE

Publication Number WO/2002/002109
Publication Date 10.01.2002
International Application No. PCT/EP2001/006935
International Filing Date 20.06.2001
Chapter 2 Demand Filed 08.01.2002
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
365
Lactones
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
307
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
77
ortho- or peri-condensed with carbocyclic rings or ring systems
93
condensed with a ring other than six-membered
A61K 31/365 (2006.01)
C07D 307/93 (2006.01)
CPC
A61K 31/365
C07D 307/93
Applicants
  • INSTITUT FÜR BIOTECHNOLOGIE UND WIRKSTOFF-FORSCHUNG E.V. [DE/DE]; Erwin-Schrödinger-Str. 56 67663 Kaiserslautern, DE (AllExceptUS)
  • BAUMGARTEN, Jörg [DE/DE]; DE (UsOnly)
  • WEIDLER, Marcus [DE/DE]; DE (UsOnly)
  • ERKEL, Gerhard [DE/DE]; DE (UsOnly)
  • ANKE, Heidrun [DE/DE]; DE (UsOnly)
  • ANKE, Timm [DE/DE]; DE (UsOnly)
Inventors
  • BAUMGARTEN, Jörg; DE
  • WEIDLER, Marcus; DE
  • ERKEL, Gerhard; DE
  • ANKE, Heidrun; DE
  • ANKE, Timm; DE
Agents
  • NOBBE, Matthias; Viering, Jentschura & Partner Centroallee 263 46047 Oberhausen, DE
Priority Data
100 32 242.503.07.2000DE
100 47 295.825.09.2000DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) VERWENDUNG VON GALIELLA-LACTON
(EN) USE OF GALIELLA LACTONE
(FR) UTILISATION DE LACTONE DE GALIELLE
Abstract
(DE)
Die Erfindung betrifft die Verwendung der unter dem Namen Galiella-Lacton bekannten Substanz als Arzneimittel, insbesondere zur Behandlung von entzündlichen Prozessen.
(EN)
The invention relates to the use of the substance known as galiella lactone as a pharmaceutical, especially for treating inflammatory processes.
(FR)
L'invention concerne l'utilisation de la substance connue sous le nom de lactone de galielle comme médicament, en particulier pour le traitement de processus inflammatoires.
Latest bibliographic data on file with the International Bureau